Clinical Trial

Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, it was observed in people without diabetes that fasting can be detrimental to the hormonal and hepatic responses to insulin-induced hypoglycemia. In the experiments described herein, the impact fasting has on hypoglycemic counterregulation in people with T1D will be determined.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-25; most recent amendment 2024-08-29.
Trial Details
NCT Number NCT05973799
Lead Sponsor University of Cincinnati
Conditions Hypoglycemia, Type1diabetes
Enrollment 10 participants
Start Date 2019-10-10
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-03